<![CDATA[Biotech boom ahead in 2024, top Jefferies analyst predicts]]>Michael Yee, Jefferies Senior Biotech Analyst, joins 'Fast Money' to talk a possible boom ahead for the biotech sector.

]]>https://dev.proinvestor.com/forum/topic/446127/biotech-boom-ahead-in-2024-top-jefferies-analyst-predictsRSS for NodeSat, 20 Jun 2026 11:57:43 GMTSun, 04 Feb 2024 10:29:06 GMT60<![CDATA[Reply to Biotech boom ahead in 2024, top Jefferies analyst predicts on Mon, 05 Feb 2024 12:18:45 GMT]]>Buy or bail on biotech: Here's what you need to know

]]>https://dev.proinvestor.com/forum/post/9486923https://dev.proinvestor.com/forum/post/9486923Mon, 05 Feb 2024 12:18:45 GMT<![CDATA[Reply to Biotech boom ahead in 2024, top Jefferies analyst predicts on Sun, 04 Feb 2024 13:50:44 GMT]]>Jeg skriver om Bristol Myers der omtales i morgen. Jeg syntes ikke det er en oplagt case endnu.
Man bruge cashflow til at finansiere en spændende pipeline samtidig med man integrer 3-4 selskaber.
Det er usikkerhed * usikkerhed = svært at lokke investorer ind.

]]>https://dev.proinvestor.com/forum/post/9486925https://dev.proinvestor.com/forum/post/9486925Sun, 04 Feb 2024 13:50:44 GMT